Skip to main content

Bio Defense

NCBiotech’s Bio Defense program probes the connections between North Carolina’s $38 billion defense industry and the life sciences.

You may immediately think of bioterrorism, but North Carolina’s small companies, researchers and military representatives are thinking more broadly: providing vaccines for soldiers; protecting the food supply; and deploying novel technologies that will protect our soldiers and heal those who sustain wounds in battle.

Military and homeland Bio Defense development is a critical need for our nation and is also an area that has application to commercial areas of biosciences. North Carolina has numerous assets and areas of overlap that could provide support for several aspects of this critical need.

The North Carolina Biotechnology Center and our partners are working to develop a strategy that is aimed at increasing defense funding in North Carolina by aligning NC’s well-recognized strengths in the life science sector with the Department of Defense (DoD) and national security strategic priorities. This initiative is an opportunity for the broader NC life science community to bring their innovative technological expertise to bear on critical challenges faced by the military and national security agencies on behalf of our state and country.

What is the North Carolina Biotechnology Center doing in support of Bio Defense? We are:

  • Providing support for researchers seeking DoD funding

  • Providing support to small businesses with a bio defense life science focus

  • Providing support for university-based research in bio defense

  • Promoting and advertising regional and national bio defense and military healthcare conferences and events

  • Representing North Carolina at targeted military and federal bio defense conferences throughout the United States and promoting our state's life science industry

  • Hosting conferences (where military, government, academic and industry experts can network and collaborate) including the 2014 NC Bio Defense Summit, Ebola Conference, and Grantsmanship Training

  • Connecting key military, industry and academia partners to promote North Carolina’s bio defense capabilities at the state and federal level

  • Watching and reviewing DoD SBIR and STTR announcement solicitations relevant to North Carolina’s biotechnology sector

  • Developing a database of North Carolina’s Defense Assets

BARDA Issues Three New Board Agency Announcements in Biodefense

The Biomedical Advanced Research Development Authority (BARDA) recently issued three advanced pre-solicitation Broad Agency Announcements (BAAs) for advanced research and development in support of medical countermeasures relative to pandemic influenza, infectious diseases, and chemical, biological, radiological, and nuclear (CBRN) threats.

BARDA manages Project BioShield, a program to procure and develop advanced medical countermeasures according to priorities given by national strategies against pandemic flu and CBRN threats. Funding through these BAAs will be evaluated based on relevance to medical countermeasure priorities as presented in the following  publications:  2014 PHEMCE Implementation Plan for CBRN Threats, the National Strategy for Pandemic Influenza, the 2010 HHS Public Health Emergency Medical Countermeasures Enterprise Review; and, the BARDA Strategic Plan 2011-2016.

Please click on the below links for further information and instructions:

  • BAA-16-100-SOL-00001 - Advanced Research and Development of CBRN Medical Countermeasures
  • BAA-16-100-SOL-00002 - Advanced Development of Medical Countermeasures for Pandemic Influenza
  • BAA-16-100-SOL-00003 - Advanced Research and Development to Expedite the Identification, Development, and Manufacturing of Medical Countermeasures against Infectious Diseases

Business North Carolina magazine, with the help from the North Carolina Biotechnology Center, held a roundtable of distinguished experts discussing opportunities for growing the Bio Defense sector in North Carolina. You can read an excerpt of the discussion in the April 2015 print edition or read it online here.